Verition Fund Management LLC Vanda Pharmaceuticals Inc. Transaction History
Verition Fund Management LLC
- $23.6 Billion
- Q4 2024
A detailed history of Verition Fund Management LLC transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 41,945 shares of VNDA stock, worth $197,141. This represents 0.0% of its overall portfolio holdings.
Number of Shares
41,945
Previous 40,285
4.12%
Holding current value
$197,141
Previous $188,000
6.38%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding VNDA
# of Institutions
155Shares Held
43.7MCall Options Held
33.8KPut Options Held
28.7K-
Black Rock Inc. New York, NY8.14MShares$38.2 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.85MShares$18.1 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.51MShares$16.5 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.49MShares$11.7 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.35MShares$11.1 Million0.85% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $266M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...